0000899243-18-031567.txt : 20181221 0000899243-18-031567.hdr.sgml : 20181221 20181221142642 ACCESSION NUMBER: 0000899243-18-031567 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170720 FILED AS OF DATE: 20181221 DATE AS OF CHANGE: 20181221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH CENTRAL INDEX KEY: 0000897680 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54716 FILM NUMBER: 181248974 FORMER NAME: FORMER CONFORMED NAME: MAYO FOUNDATION DATE OF NAME CHANGE: 19930222 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROONE MEDICAL TECHNOLOGIES Corp CENTRAL INDEX KEY: 0001500198 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 270863354 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 10006 LIATRIS LANE CITY: EDEN PRAIRIE STATE: MN ZIP: 55347 BUSINESS PHONE: (952) 237-7412 MAIL ADDRESS: STREET 1: 10006 LIATRIS LANE CITY: EDEN PRAIRIE STATE: MN ZIP: 55347 FORMER COMPANY: FORMER CONFORMED NAME: Original Source Entertainment, Inc. DATE OF NAME CHANGE: 20100830 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2017-07-20 0 0001500198 NEUROONE MEDICAL TECHNOLOGIES Corp NMTC 0000897680 MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH 200 FIRST STREET SW ROCHESTER MN 55905 0 0 1 0 Common Stock, par value $0.001 859976 D On July 20, 2017, pursuant to an Agreement and Plan of Merger and Reorganization dated July 20, 2017 (the "Merger Agreement') by and among the Issuer, OSOK Acquisition Company and NeuroOne, NeuroOne became the wholly-owned subsidiary of the Issuer (the "Merger". Pursuant to the terms of the Merger Agreement, each issued and outstanding share of common stock of NeuroOne, par value $0.0001 per share, or the NeuroOne Shares, were exchanged for 17.0103706 shares of Common Stock. Accordingly, the Reporting Person received from the Issuer 859,976 shares of Common Stock as consideration for its NeuroOne Shares in connection with the Merger. (Continued from footnote 2) Mayo Clinic, a Minnesota corporation ("Mayo"), is the controlling corporation of the Reporting Person and is included solely due to its control of the Reporting Person. Mayo disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that Mayo is the beneficial owner of the securities for purposes of Section 13 or any other purpose. Harry N. Hoffman, Co-Chief Investment Officer, on behalf of Mayo Foundation for Medical Education and Research 2018-12-20